Guobang Pharma Ltd. (SHA:605507)
China
· Delayed Price · Currency is CNY 24.22
+0.36 (1.51%)
Apr 29, 2026, 3:00 PM CST
Guobang Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | 1,512 | 1,460 | 1,909 | 2,094 | 1,974 | 893.01 | Upgrade
|
| Trading Asset Securities | 1,254 | 1,243 | 617.66 | 465.99 | 824.56 | 1,258 | Upgrade
|
| Cash & Short-Term Investments | 2,765 | 2,703 | 2,527 | 2,560 | 2,799 | 2,151 | Upgrade
|
| Cash Growth | 18.55% | 6.96% | -1.29% | -8.52% | 30.09% | 74.24% | Upgrade
|
| Accounts Receivable | 1,604 | 1,394 | 1,332 | 964.92 | 775.34 | 571.5 | Upgrade
|
| Other Receivables | 6.78 | 43.32 | 67.35 | 17.22 | 21.07 | 45.03 | Upgrade
|
| Receivables | 1,610 | 1,438 | 1,399 | 982.14 | 796.41 | 616.53 | Upgrade
|
| Inventory | 1,741 | 1,776 | 1,363 | 1,369 | 1,409 | 1,309 | Upgrade
|
| Prepaid Expenses | - | - | - | - | - | 0.7 | Upgrade
|
| Other Current Assets | 415.48 | 195.95 | 584.67 | 532.31 | 125.15 | 489.48 | Upgrade
|
| Total Current Assets | 6,532 | 6,113 | 5,874 | 5,443 | 5,129 | 4,567 | Upgrade
|
| Property, Plant & Equipment | 4,303 | 4,289 | 4,344 | 4,330 | 3,284 | 2,622 | Upgrade
|
| Long-Term Investments | 116.95 | 118.71 | 112.57 | 121.13 | 101.37 | 17.11 | Upgrade
|
| Goodwill | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Other Intangible Assets | 341.69 | 342.65 | 350.83 | 358.85 | 370.5 | 272.26 | Upgrade
|
| Long-Term Deferred Tax Assets | 13.59 | 13.52 | 8.96 | 7.78 | 6.59 | 19.02 | Upgrade
|
| Long-Term Deferred Charges | 6.86 | 6.98 | 7.45 | 8.02 | 9.26 | 2.6 | Upgrade
|
| Other Long-Term Assets | 82.08 | 100.91 | 82.64 | 92.64 | 142.61 | 12.79 | Upgrade
|
| Total Assets | 11,396 | 10,985 | 10,780 | 10,362 | 9,043 | 7,513 | Upgrade
|
| Accounts Payable | 1,466 | 1,196 | 1,704 | 1,715 | 974.35 | 789.71 | Upgrade
|
| Accrued Expenses | 62.03 | 129.85 | 125.97 | 97.06 | 107.06 | 100.47 | Upgrade
|
| Short-Term Debt | 511.07 | 512.2 | 181.23 | 488.79 | 664.28 | 168.88 | Upgrade
|
| Current Portion of Long-Term Debt | 400.32 | 7.29 | 452.17 | 28.88 | - | - | Upgrade
|
| Current Income Taxes Payable | 52.1 | 23.75 | 22.47 | 18.44 | 4.26 | 30.24 | Upgrade
|
| Current Unearned Revenue | 43.79 | 25.35 | 39.93 | 55.85 | 52.79 | 30.68 | Upgrade
|
| Other Current Liabilities | 35.69 | 26.53 | 32.34 | 45.99 | 59.64 | 33.53 | Upgrade
|
| Total Current Liabilities | 2,571 | 1,921 | 2,558 | 2,450 | 1,862 | 1,154 | Upgrade
|
| Long-Term Debt | 82.88 | 478.01 | 146.72 | 451.7 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 25.05 | 25.86 | 16.67 | 11.8 | 14.27 | 9.71 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 1.09 | 3.94 | 7.2 | 11.32 | 11.93 | 4.16 | Upgrade
|
| Total Liabilities | 2,680 | 2,429 | 2,728 | 2,924 | 1,889 | 1,167 | Upgrade
|
| Common Stock | 558.82 | 558.82 | 558.82 | 558.82 | 558.82 | 558.82 | Upgrade
|
| Additional Paid-In Capital | 3,627 | 3,627 | 3,609 | 3,607 | 3,607 | 3,607 | Upgrade
|
| Retained Earnings | 4,527 | 4,367 | 3,881 | 3,266 | 2,989 | 2,180 | Upgrade
|
| Treasury Stock | - | - | -1.48 | - | - | - | Upgrade
|
| Total Common Equity | 8,714 | 8,553 | 8,047 | 7,432 | 7,155 | 6,346 | Upgrade
|
| Minority Interest | 1.93 | 2.43 | 4.72 | 5.15 | -0.65 | -0.39 | Upgrade
|
| Shareholders' Equity | 8,716 | 8,556 | 8,052 | 7,437 | 7,155 | 6,346 | Upgrade
|
| Total Liabilities & Equity | 11,396 | 10,985 | 10,780 | 10,362 | 9,043 | 7,513 | Upgrade
|
| Total Debt | 994.27 | 997.5 | 780.12 | 969.37 | 664.28 | 168.88 | Upgrade
|
| Net Cash (Debt) | 1,771 | 1,705 | 1,747 | 1,591 | 2,134 | 1,982 | Upgrade
|
| Net Cash Growth | 38.43% | -2.37% | 9.81% | -25.46% | 7.66% | 528.79% | Upgrade
|
| Net Cash Per Share | 3.21 | 3.08 | 3.13 | 2.86 | 3.82 | 3.87 | Upgrade
|
| Filing Date Shares Outstanding | 558.82 | 558.82 | 558.37 | 555.51 | 558.82 | 558.82 | Upgrade
|
| Total Common Shares Outstanding | 558.82 | 558.82 | 558.74 | 558.82 | 558.82 | 558.82 | Upgrade
|
| Working Capital | 3,961 | 4,192 | 3,317 | 2,994 | 3,267 | 3,414 | Upgrade
|
| Book Value Per Share | 15.59 | 15.31 | 14.40 | 13.30 | 12.80 | 11.36 | Upgrade
|
| Tangible Book Value | 8,372 | 8,210 | 7,696 | 7,073 | 6,785 | 6,074 | Upgrade
|
| Tangible Book Value Per Share | 14.98 | 14.69 | 13.77 | 12.66 | 12.14 | 10.87 | Upgrade
|
| Buildings | - | 1,893 | 1,812 | 1,706 | 1,025 | 810.75 | Upgrade
|
| Machinery | - | 4,256 | 3,980 | 3,372 | 2,487 | 1,933 | Upgrade
|
| Construction In Progress | - | 282.88 | 255.26 | 636.65 | 874.85 | 827.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.